Phil Kim is a partner in the Corporate and Securities Practice Group in the firm's Dallas office.
Phil advises various types of healthcare providers in connection with transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups (including non-profit health organizations, or NPHOs), home health providers, and other healthcare companies on the buy- and sellside of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil has a particular interest in digital health. He has assisted a number of multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology.
He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters involved in the public securities offerings for such healthcare companies. Phil’s client relationships are characterized by an authenticity – he communicates honestly and directly so that clients can understand issues from all perspectives and make decisions that will serve their best interests.
Articles in the National Law Review database by Phil Kim